Impaired interleukin-8 chemokine secretion by Staphylococcus aureus - Activated epithelium and T-cell chemotaxis in cystic fibrosis

American Journal of Respiratory Cell and Molecular Biology

Volumn 42, Issue 6, 2010, Pages 644-650

  Al Alam, Denise ^a,d   Deslee, Gaetan ^b,c   Tournois, Claire ^a   Lamkhioued, Bouchaib ^a   Lebargy, François ^b,c   Merten, Marc ^c   Belaaouaj, Azzaq ^c   Guenounou, Moncef ^a   Gangloff, Sophie Catherine ^a  

^a UNIVERSITÉ DE REIMS CHAMPAGNE ARDENNE   (France)

^b REIMS UNIVERSITY HOSPITAL   (France)

^c INSERM   (France)

^d CHILDREN S HOSPITAL LOS ANGELES   (United States)

Author keywords

Airway epithelial cells; Chemokines; Cystic fibrosis; Staphylococcus aureus; T lymphocytes

Indexed keywords

CHEMOKINE RECEPTOR CCR3; CHEMOKINE RECEPTOR CCR5; CHEMOKINE RECEPTOR CCR7; CHEMOKINE RECEPTOR CXCR1; CHEMOKINE RECEPTOR CXCR2; CXCL1 CHEMOKINE; CXCL9 CHEMOKINE; CYTOKINE; INTERLEUKIN 8; MACROPHAGE INFLAMMATORY PROTEIN 3BETA; MONOCYTE CHEMOTACTIC PROTEIN 1; CD3 ANTIGEN; IL8 PROTEIN, HUMAN; MONOCLONAL ANTIBODY; RECOMBINANT PROTEIN;

ADULT; ARTICLE; ASPERGILLUS FUMIGATUS; BURKHOLDERIA CEPACIA; CD3+ T LYMPHOCYTE; CELL CULTURE; CELL GROWTH; CELL INTERACTION; CELL STIMULATION; CHEMOTAXIS; CLINICAL ARTICLE; CONTROLLED STUDY; CYSTIC FIBROSIS; CYTOKINE RELEASE; EPITHELIUM CELL; FEMALE; HAEMOPHILUS INFLUENZAE; HUMAN; HUMAN CELL; MALE; PSEUDOMONAS AERUGINOSA; QUANTITATIVE ANALYSIS; RESPIRATORY EPITHELIUM; STAPHYLOCOCCUS AUREUS; T LYMPHOCYTE; CASE CONTROL STUDY; CELL LINE; IMMUNOLOGY; IMPEDANCE; MICROBIOLOGY; NEUTROPHIL CHEMOTAXIS; PATHOGENICITY; RESPIRATORY TRACT MUCOSA; SECRETION; TIME;

STAPHYLOCOCCUS AUREUS;

ADULT; ANTIBODIES, MONOCLONAL; ANTIGENS, CD3; CASE-CONTROL STUDIES; CELL LINE; CHEMOTAXIS, LEUKOCYTE; CYSTIC FIBROSIS; ELECTRIC IMPEDANCE; FEMALE; HUMANS; INTERLEUKIN-8; MALE; RECEPTORS, INTERLEUKIN-8A; RECOMBINANT PROTEINS; RESPIRATORY MUCOSA; STAPHYLOCOCCUS AUREUS; T-LYMPHOCYTES; TIME FACTORS; YOUNG ADULT;

EID: 77953259921     PISSN: 10441549     EISSN: None     Source Type: Journal    
DOI: 10.1165/rcmb.2008-0021OC     Document Type: Article

References (49)

1. Pilewski JM, Frizzell RA. Role of CFTR in airway disease. Physiol Rev 1999;79(Suppl)S215-S255.
2. Souza HA, Nogueira KS, Matos AP, Vieira RP, Riedi CA, Rosário NA, Telles FQ, Costa LM. Early microbial colonization of cystic fibrosis patients identified by neonatal screening, with emphasis on Staphylococcus aureus. J Pediatr (Rio J) 2006;82:377-382.
3. Tirouvanziam R, de Bentzmann S, Hubeau C, Hinnrasky J, Jacquot J, Peault B, Puchelle E. Inflammation and infection in naive human cystic fibrosis airway grafts. Am J Respir Cell Mol Biol 2000;23:121-127. (Pubitemid 30656417)
4. Llewelyn M, Cohen J. Superantigens: microbial agents that corrupt immunity. Lancet Infect Dis 2002;2:156-162. (Pubitemid 34462450)
5. Moraes TJ, Plumb J, Martin R, Vachon E, Cherepanov V, Koh A, Loeve C, Jongstra-Bilen J, Zurawska JH, Kus JV, et al. Abnormalities in the pulmonary innate immune system in cystic fibrosis. Am J Respir Cell Mol Biol 2006;34:364-374.
6. Blackwell TS, Stecenko AA, Christman JW. Dysregulated NF-kappaB activation in cystic fibrosis: evidence for a primary inflammatory disorder. Am J Physiol Lung Cell Mol Physiol 2001;281:L69-L70.
7. Stecenko AA, King G, Torii K, Breyer RM, Dworski R, Blackwell TS, Christman JW, Brigham KL. Dysregulated cytokine production in human cystic fibrosis bronchial epithelial cells. Inflammation 2001;25: 145-155. (Pubitemid 32493687)
8. Verhaeghe C, Delbecque K, de Leval L, Oury C, Bours V. Early inflammation in the airways of a cystic fibrosis foetus. J Cyst Fibros 2007;6:304-308. (Pubitemid 46971896)
9. Muhlebach MS, Noah TL. Endotoxin activity and inflammatory markers in the airways of young patients with cystic fibrosis. Am J Respir Crit Care Med 2002;165:911-915.
10. Muhlebach MS, Reed W, Noah TL. Quantitative cytokine gene expression in CF airway. Pediatr Pulmonol 2004;37:393-399. (Pubitemid 38620060)
11. Khan TZ, Wagener JS, Bost T, Martinez J, Accurso FJ, Riches DW. Early pulmonary inflammation in infants with cystic fibrosis. Am J Respir Crit Care Med 1995;151:1075-1082.
12. Marguet C, Jouen-Boedes F, Dean TP, Warner JO. Bronchoalveolar cell profiles in children with asthma, infantile wheeze, chronic cough, or cystic fibrosis. Am J Respir Crit Care Med 1999;159:1533-1540. (Pubitemid 29227865)
13. Moss RB. Lymphocytes in cystic fibrosis lung disease: a tale of two immunities. Clin Exp Immunol 2004;135:358-360. (Pubitemid 38297135)
14. Hubeau C, Lorenzato M, Couetil JP, Hubert D, Dusser D, Puchelle E, Gaillard D. Quantitative analysis of inflammatory cells infiltrating the cystic fibrosis airway mucosa. Clin Exp Immunol 2001;124:69-76. (Pubitemid 32476936)
15. Escotte S, Al Alam D, Le Naour R, Puchelle E, Guenounou M, Gangloff SC. T cell chemotaxis and chemokine release after Staphylococcus aureus interaction with polarized airway epithelium. Am J Respir Cell Mol Biol 2006;34:348-354. (Pubitemid 43320716)
16. Merten MD, Kammouni W, Renaud W, Birg F, Mattei MG, Figarella C. A transformed human tracheal gland cell line, MM-39 that retains serous secretory functions. Am J Respir Cell Mol Biol 1996;15:520-528. (Pubitemid 126440579)
17. Kammouni W, Moreau B, Becq F, Saleh A, Pavirani A, Figarella C, Merten MD. A cystic fibrosis tracheal gland cell line, CF-KM4: correction by adenovirus-mediated CFTR gene transfer. Am J Respir Cell Mol Biol 1999;20:684-691. (Pubitemid 129495656)
18. Taub DD, Key ML, Clark D, Turcovski-Corrales SM. Chemotaxis of T lymphocytes on extracellular matrix proteins; analysis of the in vitro method to quantitate chemotaxis of human T cells. J Immunol Methods 1995;184:187-198.
19. Lamkhioued B, Renzi PM, Abi-Younes S, Garcia-Zepada EA, Allakhverdi Z, Ghaffar O, Rothenberg MD, Luster AD, Hamid Q. Increased expression of eotaxin in bronchoalveolar lavage and airways of asthmatics contributes to the chemotaxis of eosinophils to the site of inflammation. J Immunol 1997;159:4593-4601. (Pubitemid 127470622)
20. Moreilhon C, Gras D, Hologne C, Bajolet O, Cottrez F, Magnone V, Merten M, Groux H, Puchelle E, Barbry P. Live Staphylococcus aureus and bacterial soluble factors induce different transcriptional responses in human airway cells. Physiol Genomics 2005;20:244-255. (Pubitemid 40388524)
21. Da Silva MC, Zahm JM, Gras D, Bajolet O, Abely M, Hinnrasky J, Milliot M, de Assis MC, Hologne C, Bonnet N, et al. Dynamic interaction between airway epithelial cells and Staphylococcus aureus. Am J Physiol Lung Cell Mol Physiol 2004;287:L543-L551. (Pubitemid 39095910)
22. Rejman J, Di Gioia S, Bragonzi A, Conese M. Pseudomonas aeruginosa infection destroys the barrier function of lung epithelium and enhances polyplex-mediated transfection. Hum Gene Ther 2007;18: 642-652. (Pubitemid 47187095)
23. Rajan S, Cacalano G, Bryan R, Ratner AJ, Sontich CU, van Heerckeren A, Davis P, Prince A. Pseudomonas aeruginosa induction of apoptosis in respiratory epithelial cells: analysis of the effects of cystic fibrosis transmembrane conductance regulator dysfunction and bacterial virulence factors. Am J Respir Cell Mol Biol 2000;23:304-312.
24. Plotkowski MC, de Bentzmann S, Pereira SH, Zahm JM, Bajolet-Laudinat O, Roger P, Puchelle E. Pseudomonas aeruginosa internalization by human epithelial respiratory cells depends on cell differentiation, polarity, and junctional complex integrity. Am J Respir Cell Mol Biol 1999;20:880-890. (Pubitemid 129540847)
25. Reiniger N, Ichikawa JK, Pier GB. Influence of cystic fibrosis transmembrane conductance regulator on gene expression in response to Pseudomonas aeruginosa infection of human bronchial epithelial cells. Infect Immun 2005;73:6822-6830. (Pubitemid 41368849)
26. Campodónico VL, Gadjeva M, Paradis-Bleau C, Uluer A, Pier GB. Airway epithelial control of Pseudomonas aeruginosa infection in cystic fibrosis. Trends Mol Med 2008;14:120-133.
27. Machen TE. Innate immune response in CF airway epithelia: hyperinflammatory? Am J Physiol Cell Physiol 2006;291:C218-C230.
28. Carrabino S, Carpani D, Livraghi A, Di Cicco M, Costantini D, Copreni E, Colombo C, Conese M. Dysregulated interleukin-8 secretion and NF-kappaB activity in human cystic fibrosis nasal epithelial cells. J Cyst Fibros 2006;5:113-119.
29. Tabary O, Escotte S, Couetil JP, Hubert D, Dusser D, Puchelle E, Jacquot J. High susceptibility for cystic fibrosis human airway gland cells to produce IL-8 through the I kappa B kinase alpha pathway in response to extracellular NaCl content. J Immunol 2000;164:3377-3384. (Pubitemid 30149004)
30. Verhaeghe C, Remouchamps C, Hennuy B, Vanderplasschen A, Chariot A, Tabruyn SP, Oury C, Bours V. Role of IKK and ERK pathways in intrinsic inflammation of cystic fibrosis airways. Biochem Pharmacol 2007;73:1982-1994. (Pubitemid 46677911)
31. Hartl D, Griese M, Kappler M, Zissel G, Reinhardt D, Rebhan C, Schendel DJ, Krauss-Etschmann S. Pulmonary Th2 response in Pseudomonas aeruginosa-infected patients with cystic fibrosis. J Allergy Clin Immunol 2006;117:204-211. (Pubitemid 43017162)
32. DiMango E, Ratner AJ, Bryan R, Tabibi S, Prince A. Activation of NF-kappaB by adherent Pseudomonas aeruginosa in normal and cystic fibrosis respiratory epithelial cells. J Clin Invest 1998;101: 2598-2605. (Pubitemid 28270454)
33. Becker MN, Sauer MS, Muhlebach MS, Hirsh AJ, Wu Q, Verghese MW, Randell SH. Cytokine secretion by cystic fibrosis airway epithelial cells. Am J Respir Crit Care Med 2004;169:645-653. (Pubitemid 38270902)
34. Wiszniewski L, Jornot L, Dudez T, Pagano A, Rochat T, Lacroix JS, Suter S, Chanson M. Long-term cultures of polarized airway epithelial cells from patients with cystic fibrosis. Am J Respir Cell Mol Biol 2006;34: 39-48. (Pubitemid 43042855)
35. Loetscher M, Gerber B, Loetscher P, Jones SA, Piali L, Clark-Lewis I, Baggioloni M, Moser C. Chemokine receptor specific for IP10 and mig: structure, function, and expression in activated T-lymphocytes. J Exp Med 1996;184:963-969. (Pubitemid 26313554)
36. Loetscher M, Loetscher P, Brass N, Meese E, Moser B. Lymphocyte-specific chemokine receptor CXCR3: regulation, chemokine binding and gene localization. Eur J Immunol 1998;28:3696-3705. (Pubitemid 28510780)
37. Kim CH, Pelus LM, White JR, Broxmeyer HE. Differential chemotactic behavior of developing T cells in response to thymic chemokines. Blood 1998a;91:4434-4443.
38. Kim CH, Pelus LM, White JR, Applebaum E, Johanson K, Broxmeyer HE. CK beta-11/macrophage inflammatory protein-3 beta/EBI1-ligand chemokine is an efficacious chemoattractant for T and B cells. J Immunol 1998b;160:2418-2424. (Pubitemid 28119926)
39. Gibejova A, Mrazek F, Subrtova D, Sekerova V, Szotkowska J, Kolek V, Du Bois RM, Petrek M. Expression of macrophage inflammatory protein-3 beta/CCL19 in pulmonary sarcoidosis. Am J Respir Crit Care Med 2003;167:1695-1703. (Pubitemid 36760685)
40. Moser C, Kjaergaard S, Pressler T, Kharazmi A, Koch C, Hoiby N. The immune response to chronic Pseudomonas aeruginosa lung infection in cystic fibrosis patients is predominantly of the Th2 type. APMIS 2000;108:329-335. (Pubitemid 30456361)
41. Takata H, Tomiyama H, Fujiwara M, Kobayashi N, Takiguchi M. Expression of chemokine receptor CXCR1 on Human Effector CD8+ T cells. J Immunol 2004;173:2231-2235.
42. Francis NJ, Jacobson MR, Lloyd CM, Sabroe I, Durham SR, Till SJ. CXCR1+CD4+ T cells in HUMAN ALLERGIC DISEase. J Immunol 2004;172:268-273.
43. Nagira M, Imai T, Yoshida R, Takagi S, Iwasaki M, Baba M, Tabira Y, Akagi J, Nomiyama H, Yoshie O. A lymphocyte-specific CC chemokine, secondary lymphoid tissue chemokine (SLC), is a highly efficient chemoattractant for B cells and activated T cells. Eur J Immunol 1998;28:1516-1523. (Pubitemid 28221154)
44. Pignatti P, Brunetti G, Moretto D, Yacoub MR, Fiori M, Balbi B, Balestrino A, Cervio G, Nava S, Moscato G. Role of the chemokine receptors CXCR3 and CCR4 in human pulmonary fibrosis. Am J Respir Crit Care Med 2006;173:310-317. (Pubitemid 43209086)
45. Katchar K, Eklund A, Grunewald J. Expression of Th1 markers by lung accumulated T cells in pulmonary sarcoidosis. J Intern Med 2003;254: 564-571. (Pubitemid 37521853)
46. Campbell JJ, Brightling CE, Symon FA, Qin S, Murphy KE, Hodge M, Andrew DP, Wu L, Butcher EC, Wardlaw AJ. Expression of chemokine receptors by lung T cells from normal and asthmatic subjects. J Immunol 2001;166:2842. (Pubitemid 32173526)
47. Costa C, Rufino R, Traves SL, Lapa E, Silva JR, Barnes PJ, Donnelly LE. CXCR3 and CCR5 chemokines in induced sputum from patients with COPD. Chest 2008;133:26-33.
48. Medoff BD, Thomas SY, Luster AD. T cell trafficking in allergic asthma: the ins and outs. Annu Rev Immunol 2008;26:205-232.
49. Francis JN, Sabroe I, Lloyd CM, Durham SR, Till SJ. Elevated CCR6+ CD41 T lymphocytes in tissue compared with blood and induction of CCL20 during the asthmatic late response. Clin Exp Immunol 2008; 152:440-447. (Pubitemid 351661508)